Trial intelligence / Profile preview

Low dose hCG and FSH co-trigger in IVF

NCT02310919Phase 3Completed

Sponsor
University of California, San Francisco
Start
Sep 2014
Primary completion
Jun 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of follitropin in infertility, sponsored by University of California, San Francisco. Primary endpoint: Total Fertilization Proportion (Total Competent Proportion) at 2 days. Started Sep 2014; status: completed.

02

Drugs

follitropin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT02310919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02310919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call